Fewer than half of ob/gyns counsel pregnant patients on risk of congenital cytomegalovirus and on preventive measures.
Fewer than half of obstetricians and gynecologists counsel pregnant patients on the risk of congenital cytomegalovirus and on preventive measures they can take to minimize the chances of infection, according to a report published in the Jan. 25 issue of the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.
B. Anderson, PhD, of the American College of Obstetricians and Gynecologists and colleagues surveyed 305 ob/gyns on their knowledge of cytomegalovirus prevention and on their communication to pregnant patients regarding cytomegalovirus.
Although 90% said they knew that the risk of cytomegalovirus infection during pregnancy could be reduced by handwashing, only 60% reported advising their pregnant patients to do so, and only 44% counseled their patients specifically on avoiding cytomegalovirus infection. Since 2003, nearly 27% of respondents had diagnosed cytomegalovirus infection in a pregnant patient.
Centers for Disease Control and Prevention (CDC). Knowledge and practices of obstetricians and gynecologists regarding cytomegalovirus infection during pregnancy-United States, 2007. MMWR Morb Mortal Wkly Rep. 2008;57:65-68.
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More